We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

This study has been terminated.
(Manufacturer ceased to produce vials used for this study.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01091051
First Posted: March 23, 2010
Last Update Posted: June 11, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Janssen-Ortho LLC
Information provided by (Responsible Party):
Innovaderm Research Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)